FIELD: pharmaceutics.
SUBSTANCE: the present innovation deals with peroral liquid compositions which could be designed into gelatinous capsules. The suggested pharmaceutical composition includes a pharmaceutically active agent, a solubilizing agent and, not obligatory, a surface-active substance and a plastifying agent. The pharmaceutically active agent has got, at least, one acidic fragment, preferrably, that of carbonic acid being chosen out of the group of non steroid antiphlogistic preparations being acid-soluble at acid : dissolved substance ratio being from 3:1 to 10000:1. New compositions provide increased rates and degrees of absorption of pharmaceutically active agent and minimize side effects caused by such active substances.
EFFECT: higher efficiency of application.
42 cl, 39 ex
| Title | Year | Author | Number |
|---|---|---|---|
| OPHTHALMIC COMPOSITION WITH HIGH CONCENTRATION OF OLOPATADINE | 2012 |
|
RU2613715C2 |
| ALKOXY-SUBSTITUTED BENZIMIDAZOLE COMPOUNDS, PHARMACEUTICAL PREPARATIONS COMPRISING THEREOF AND METHOD FOR THEIR USING | 2000 |
|
RU2263673C2 |
| ABT-263 CAPSULE | 2010 |
|
RU2550956C2 |
| SELF-EMULSIFYING COMPOSITION FOR SCARCELY WATER-SOLUBLE MEDICAMENT | 1999 |
|
RU2257917C2 |
| NIMESULIDE-CONTAINING SUSTAINED-RELEASE COMPOSITIONS | 2000 |
|
RU2238087C2 |
| SYNERGETIC ANALGETIC COMBINATION OF OPIOID ANALGETIC AGENT AND CYCLOOXYGENASE-2 INHIBITOR | 1998 |
|
RU2232600C2 |
| METHOD FOR SOLUBILIZATION OF 5-AMINO-2,3-DIHYDRO-1,4-PHTHALAZINEDIONE | 2019 |
|
RU2787999C2 |
| STABLE PHARMACEUTICAL COMPOSITION OF WATER-SOLUBLE SALT OF VINORELBINE | 2008 |
|
RU2476208C2 |
| SUSPENSIONS OF CRYSTALLINE PYRIMIDINE NUCLEOSIDE DERIVATIVES IN CAPSULES | 2006 |
|
RU2428972C2 |
| PHARMACEUTICAL COMPOSITION OF CARBOXAMIDE INHIBITORS OF HIV INTEGRASE, CONTAINING COMPOSITION WITH CONTROLLED RATE OF RELEASE | 2005 |
|
RU2382648C2 |
